Skip to main content

Russell Investments Group, Ltd.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA

Position in SUPN

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$2,986,438
-$1,390,637 QoQ
Shares Held
57,776
-34.4% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 87.11402658543341.ToString("F0")% Shared 0.ToString("F0")% None 12.885973414566601.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $291,116,040 across 50 Drug Manufacturers - Specialty & Generic names. SUPN ranks #14 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SUPN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,986,438 57,776
2025-12-31 $4,377,075 88,070
2025-09-30 $2,986,727 62,497
2025-06-30 $1,759,697 55,828
2025-03-31 $2,457,231 75,030
2024-12-31 $3,485,641 96,395
2024-09-30 $3,415,673 109,547
2024-06-30 $2,682,008 100,262
2024-03-31 $3,342,369 97,988
2023-12-31 $929,203 32,108
2023-09-30 $824,231 29,896
2023-06-30 $1,516,855 50,461
2023-03-31 $1,826,679 50,419
2022-12-31 $1,260,221 35,330
2022-09-30 $1,195,920 35,330
2022-06-30 $426,280 14,740
2022-03-31 $476,396 14,740
2021-12-31 $709,374 24,327
2021-09-30 $393,115 14,740
2021-06-30 $585,809 19,026
2021-03-31 $1,981,851 75,701
2020-12-31 $2,876,366 114,323
2020-09-30 $3,777,539 181,264
2020-06-30 $6,864,840 289,046
2020-03-31 $2,315,328 128,701